chevron_leftBack
As of 24 June 2026, Lakewood-Amedex Biotherapeutics Inc. has a market cap of $6.93M USD, ranking #43112 globally and #5529 in the United States.
It ranks #3810 in the Healthcare sector, and #749 in the Biotechnology industry.
Key Stats
Market Cap
$6.93MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 8.8% | -45% | -48% | -95% | -95% | -95% |
News
Loading...
LABT Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
LABT
ISIN: US51255A2015
Shares Out.:
Shares Outstanding:
1.432M1
Shares Float:
1.432M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
3.97 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
3M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
2M%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
398K%
|
-
|
|
NYSE: IQV
|
$26.3B
379K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
361K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
262K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.1B
679K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.45B
641K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$41.65B
601K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.62B
600K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$27.87B
402K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
370K%
|
-
|
chevron_leftBack